74 related articles for article (PubMed ID: 6689343)
1. A case of K cell deficiency with diabetes mellitus and Graves' disease.
Matsuzaki H; Kawano F; Nishimura H; Nagao S; Takatsuki K
J Clin Lab Immunol; 1983 Dec; 12(4):221-4. PubMed ID: 6689343
[TBL] [Abstract][Full Text] [Related]
2. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
[TBL] [Abstract][Full Text] [Related]
3. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.
Kusaka I; Nagasaka S; Fujibayashi K; Hayashi H; Kawakami A; Nakamura T; Rokkaku K; Saito T; Higashiyama M; Honda K; Ishikawa S; Saito T
Endocr J; 1999 Dec; 46(6):747-54. PubMed ID: 10724349
[TBL] [Abstract][Full Text] [Related]
4. HL-A in Graves' disease and in diabetes mellitus insulin-dependent.
Seignalet J; Mirouze J; Jaffiol C; Selam JL; Lapinski H
Tissue Antigens; 1975 Oct; 6(4):272-4. PubMed ID: 1242826
[No Abstract] [Full Text] [Related]
5. Antibody-dependent cell-mediated cytotoxicity in Graves disease.
Balázs C; Leövey A; Szerze P; Kovács L; Bordán L
Acta Med Acad Sci Hung; 1977; 34(4):235-9. PubMed ID: 581819
[TBL] [Abstract][Full Text] [Related]
6. The cell populations mediating natural killing-(NK) and antibody-dependent cell-mediated cytotoxicity are only partially identical.
Bardos P; Altman J; Guillou PJ; Carnaud C
Clin Exp Immunol; 1981 Mar; 43(3):534-9. PubMed ID: 7285391
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human lymphocyte natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity by K-76 COONa, a reagent that blocks complement activity.
Hudig D; Redelman D; Minning L; Carine K
J Immunol; 1984 Jul; 133(1):408-14. PubMed ID: 6725955
[TBL] [Abstract][Full Text] [Related]
8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
9. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
10. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
Kretowski A; Myśliwiec J; Kinalska I
Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
[TBL] [Abstract][Full Text] [Related]
11. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
12. Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.
Smyth MJ; Johnstone RW; Cretney E; Haynes NM; Sedgwick JD; Korner H; Poulton LD; Baxter AG
J Immunol; 1999 Aug; 163(3):1350-3. PubMed ID: 10415034
[TBL] [Abstract][Full Text] [Related]
13. Natural killer activity of human lymphocytes against colon cancer cells.
Helms RA; Bull DM
Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
[TBL] [Abstract][Full Text] [Related]
14. The alterations of CD11A expression on peripheral blood lymphocytes/monocytes and CD62L expression on peripheral blood lymphocytes in Graves' disease and type 1 diabetes.
Kretowski A; Myśliwiec J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():151-9. PubMed ID: 10697430
[TBL] [Abstract][Full Text] [Related]
15. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease.
Hiromatsu Y; Mukai T; Kaku H; Miyake I; Ichimura M; Fukutani T; Nakayama H; Takata K; Imamura Y; Shoji S; Yamada K; Koda Y; Bednarczuk T
Diabet Med; 2006 Feb; 23(2):211-5. PubMed ID: 16433722
[TBL] [Abstract][Full Text] [Related]
16. Age dependence of spontaneous plaque forming cells in human peripheral blood in Graves disease, rheumatoid arthritis and normal subjects.
Weetman AP
J Clin Lab Immunol; 1982 Jun; 8(2):91-3. PubMed ID: 7050390
[TBL] [Abstract][Full Text] [Related]
17. Role of natural killer T cells in Graves' disease.
Luo W; Guo H; Aosai F; Yano A
Chin Med J (Engl); 2002 Aug; 115(8):1183-5. PubMed ID: 12215288
[TBL] [Abstract][Full Text] [Related]
18. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
19. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
20. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
